Implication of Two Doses of O2-O3 Upon the Pain Alleviation in Patients With Low Back Pain
CompletedNot applicableNCT03023969
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Low back pain is very common problem, variable modalities have been introduced to control such problem. One of the emerging modalities is the ozone - oxygen (O2-O3 ) mixture that could reduce the herniation disk size and inflammation.
Study details
- Official title
- Implication of Two Different Doses of Intradiscal O2-O3 Injection Upon the Pain Alleviation in Patients With Low Back Pain: A Randomized, Single-blind Study
- Conditions
- Interventions
- Drug: ozone oxygen mixture
- Sponsor
- Assiut University
- Start date
- 2015-08
- Primary completion
- 2016-12
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * All patients Suffered radicular leg pain and some reported additional back pain. * All patients are non-responsive to conservative treatment modalities with VAS more than 7. Exclusion criteria * presence of bleeding disorder * local infection * uncontrolled or degenerative spine disease * pregnancy * multilevel disk involvement * patient refusal.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03023969